Explore

Rapid ReadRapid Read
President Trump's Budget Proposes Moving 340B Program Oversight to CMS

President Trump's Budget Proposes Moving 340B Program Oversight to CMS

President Trump's budget proposal for fiscal year 2027, released on April 3, 2026, includes a significant recommendation to transfer the oversight of the 340B Drug Pricing Program from the Health Resources & Services Administration (HRSA) to the Centers for Medicare & Medicaid Services (CMS). This proposed shift in administrative responsibility is a notable change for the program. While the budget proposal outlines the intention, an anonymous source has reportedly indicated that this transition is expected to occur in September of the same year. This move comes amidst ongoing litigation challenging the drug pricing negotiation program established under the Inflation Reduction Act (IRA), with drug manufacturers continuing to contest its provisions. Additionally, the White House announced on August 31, 2026, that nine pharmaceutical manufacturers are voluntarily participating in the Generous payment model, which implements most favored nation (MFN) pricing in Medicaid.
ReutersReuters
US consumer inflation picks up in August

US consumer inflation picks up in August

By Lucia Mutikani WASHINGTON, Sept 11 (Reuters) - U.S. consumer prices accelerated in August as the cost of gasoline rebounded after two straight monthly declines, bolstering financial market expectations that the Federal Reserve could raise interest rates next week.
ReutersReuters
Bond yields near multi-year peaks after accelerating U.S. inflation, traders add to Fed hike bets

Bond yields near multi-year peaks after accelerating U.S. inflation, traders add to Fed hike bets

By Samuel Indyk and Stella Qiu LONDON, Sept 11 (Reuters) - A selloff in global equity markets paused on Friday as oil prices retreated from a four-month high, but accelerating U.S. consumer inflation prompted traders to add to expectations for a rate hike from the Federal Reserve next week, keeping
ReutersReuters
US consumer prices accelerate in August, push Fed closer to rate hike

US consumer prices accelerate in August, push Fed closer to rate hike

By Lucia Mutikani WASHINGTON, Sept 11 (Reuters) - U.S. consumer prices accelerated in August, while a key measure of underlying inflation posted its largest increase in four months, reinforcing expectations that the Federal Reserve will raise interest rates next week.
Rapid ReadRapid Read
U.S. Rep. Buddy Carter Considered for FDA Commissioner Role, White House Selects Heidi Overton

U.S. Rep. Buddy Carter Considered for FDA Commissioner Role, White House Selects Heidi Overton

U.S. Rep. Buddy Carter (R-Ga.) was reportedly in consideration for the position of permanent FDA Commissioner. However, recent reports indicate that President Trump has instead selected White House policy aide Heidi Overton for the role. Carter, a licensed pharmacist who previously owned his own pharmacy, is set to leave Congress at the end of his current term after losing his state’s Republican primary. The search for a permanent FDA commissioner has seen several developments, with Overton's nomination now proceeding to the Senate HELP Committee for confirmation. Acting Commissioner Kyle Diamantas can continue in his role until early December under the Vacancies Act, with his term extending upon the formal submission of a nominee by the White House. The FDA's leadership structure is expected to undergo significant changes by early 2027, with new deputy commissioner roles also being planned.
Rapid ReadRapid Read
Medicare Expands Drug Price Negotiations and Adjusts Out-of-Pocket Costs for 2027

Medicare Expands Drug Price Negotiations and Adjusts Out-of-Pocket Costs for 2027

Medicare's drug price negotiation program is set to expand, with negotiated prices for an additional 15 Part D drugs taking effect on January 1, 2027. This follows the initial implementation of negotiated prices for the first 10 Part D drugs on January 1, 2026. The Centers for Medicare & Medicaid Services (CMS) continues to outline how drugs are selected, prices are calculated, and how manufacturers who decline to negotiate are handled under the Inflation Reduction Act of 2022. For 2027, the maximum standard Part D deductible will increase to $700, up from $615 in 2026. Additionally, the out-of-pocket threshold for covered Part D drugs will be capped at $2,400 for the year, an increase from $2,100 in 2026. Once this threshold is met, beneficiaries will pay $0 for covered Part D drugs for the remainder of the year. The Medicare GLP-1 Bridge program will also provide access to certain GLP-1 weight-loss medications for qualifying individuals with a $50 copayment for a monthly supply, operating differently fro...
ReutersReuters
Wall Street jumps, oil lower ahead of Fed vote next week

Wall Street jumps, oil lower ahead of Fed vote next week

By Pete Schroeder WASHINGTON, Sept 11 (Reuters) - Wall Street ticked up on Friday after a volatile, mostly down week and oil prices dipped after a week-long surge in which Gulf tensions and inflation concerns weighed on markets.
Rapid ReadRapid Read
President Trump Considers Pardon for Former Attorney Michael Cohen Amidst Reconciliation

President Trump Considers Pardon for Former Attorney Michael Cohen Amidst Reconciliation

President Trump has indicated he would consider pardoning his former attorney and fixer, Michael Cohen. This development follows a recent public reconciliation between the two, despite Cohen's past testimony against President Trump in court and before Congress, which led to Cohen being labeled a 'rat' by the President. President Trump stated, 'If everything is checking out, it’s something I would consider,' when asked about Cohen's appeal for presidential clemency. Cohen had previously submitted a pardon application to the White House after being denied by the Biden administration. While Cohen has not fully recanted his testimony, he has expressed a desire to move past his long-standing feud with President Trump, stating he 'felt pressured and coerced' into testifying. This consideration comes after President Trump joined Cohen's radio show last month, marking a significant shift in their relationship. Cohen pleaded guilty in 2018 to federal crimes, including facilitating a $130,000 hush payment to Stormy ...
Rapid ReadRapid Read
Republican Candidates Target Health Insurance Companies in Campaign Ads, Citing Polling Advantage

Republican Candidates Target Health Insurance Companies in Campaign Ads, Citing Polling Advantage

Republican candidates across the U.S. are increasingly focusing their campaign messaging on criticizing large health insurance companies, a strategy traditionally employed by Democrats. This shift is evident in competitive Senate and House races in states like Iowa, New Jersey, and Colorado. Polling data presented by President Trump's political team to Senate Republicans indicates a significant political opening, showing a 46-point advantage when Republicans advocate for greater transparency regarding insurers' profits, claim denials, and wait times, while accusing Democrats of favoring insurance companies. For instance, Iowa Republican Senate candidate Ashley Hinson launched her campaign with an ad stating that 'healthcare companies are ripping you off' and has introduced legislation requiring insurers to disclose more information about care denials and delays. Similarly, Iowa Republican Rep. Mariannette Miller-Meeks has positioned herself as the 'number one enemy' of the big insurance lobby in her campai...
AP NewsAP News
The Latest: The US marks 25 years since the Sept. 11 attacks

The Latest: The US marks 25 years since the Sept. 11 attacks

Americans are commemorating the 25th anniversary of 9/11, remembering the shock, the dead and the sweeping consequences of the al-Qaida attacks on symbols of U.S. might and prosperity
AP NewsAP News
Pills are keeping abortion accessible even where it's banned. A court is considering restrictions

Pills are keeping abortion accessible even where it's banned. A court is considering restrictions

Louisiana is making its case in federal court that mifepristone, a key drug in the most common abortion method in the U.S., should not be prescribed by telehealth or dispensed anywhere but a medical facility
AP NewsAP News
An appeals court is considering a push to restrict most common abortion method

An appeals court is considering a push to restrict most common abortion method

A panel of federal judges is considering Louisiana's assertion that mifepristone, a key drug in the most common abortion method in the U.S., should not be dispensed anywhere but a medical facility